156 related articles for article (PubMed ID: 36882341)
1. Race, ethnicity, sex, and socioeconomic disparities in anticoagulation for atrial fibrillation: A narrative review of contemporary literature.
Daly DJ; Essien UR; Del Carmen MG; Scirica B; Berman AN; Searl Como J; Wasfy JH
J Natl Med Assoc; 2023 Jun; 115(3):290-297. PubMed ID: 36882341
[TBL] [Abstract][Full Text] [Related]
2. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
[TBL] [Abstract][Full Text] [Related]
3. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.
Essien UR; Holmes DN; Jackson LR; Fonarow GC; Mahaffey KW; Reiffel JA; Steinberg BA; Allen LA; Chan PS; Freeman JV; Blanco RG; Pieper KS; Piccini JP; Peterson ED; Singer DE
JAMA Cardiol; 2018 Dec; 3(12):1174-1182. PubMed ID: 30484833
[TBL] [Abstract][Full Text] [Related]
4. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
5. Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation.
Sur NB; Wang K; Di Tullio MR; Gutierrez CM; Dong C; Koch S; Gardener H; García-Rivera EJ; Zevallos JC; Burgin WS; Rose DZ; Goldberger JJ; Romano JG; Sacco RL; Rundek T
Stroke; 2019 Jun; 50(6):1452-1459. PubMed ID: 31084325
[TBL] [Abstract][Full Text] [Related]
6. Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: An Analysis Using Administrative Claims Data.
Kim MH; Xu L; Puckrein G
Adv Ther; 2018 Nov; 35(11):2069-2080. PubMed ID: 30219991
[TBL] [Abstract][Full Text] [Related]
7. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry.
Golwala H; Jackson LR; Simon DN; Piccini JP; Gersh B; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Thomas L; Fonarow GC; Peterson ED; Thomas KL;
Am Heart J; 2016 Apr; 174():29-36. PubMed ID: 26995367
[TBL] [Abstract][Full Text] [Related]
8. Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation.
Chen N; Brooks MM; Hernandez I
JAMA Netw Open; 2020 Feb; 3(2):e1921357. PubMed ID: 32074287
[TBL] [Abstract][Full Text] [Related]
9. Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation.
Shen AY; Chen W; Yao JF; Brar SS; Wang X; Go AS
CNS Drugs; 2008; 22(10):815-25. PubMed ID: 18788834
[TBL] [Abstract][Full Text] [Related]
10. Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities.
Essien UR; Kim N; Magnani JW; Good CB; Litam TMA; Hausmann LRM; Mor MK; Gellad WF; Fine MJ
Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008389. PubMed ID: 34779655
[TBL] [Abstract][Full Text] [Related]
11. Patients' and clinicians' perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis.
Osasu YM; Cooper R; Mitchell C
BMC Fam Pract; 2021 Dec; 22(1):254. PubMed ID: 34937557
[TBL] [Abstract][Full Text] [Related]
12. Racial, ethnic, and sex disparities in atrial fibrillation management: rate and rhythm control.
Gomez SE; Fazal M; Nunes JC; Shah S; Perino AC; Narayan SM; Tamirisa KP; Han JK; Rodriguez F; Baykaner T
J Interv Card Electrophysiol; 2023 Aug; 66(5):1279-1290. PubMed ID: 36224481
[TBL] [Abstract][Full Text] [Related]
13. Racial/Ethnic and Socioeconomic Disparities in Management of Incident Paroxysmal Atrial Fibrillation.
Eberly LA; Garg L; Yang L; Markman TM; Nathan AS; Eneanya ND; Dixit S; Marchlinski FE; Groeneveld PW; Frankel DS
JAMA Netw Open; 2021 Feb; 4(2):e210247. PubMed ID: 33635328
[TBL] [Abstract][Full Text] [Related]
14. Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System.
Essien UR; Kim N; Hausmann LRM; Mor MK; Good CB; Magnani JW; Litam TMA; Gellad WF; Fine MJ
JAMA Netw Open; 2021 Jul; 4(7):e2114234. PubMed ID: 34319358
[TBL] [Abstract][Full Text] [Related]
15. Facility-Level Variation in Racial Disparities in Anticoagulation for Atrial Fibrillation: The REACH-AF Study.
Essien UR; Kim N; Hausmann LRM; Washington DL; Mor MK; Gellad WF; Fine MJ
J Gen Intern Med; 2024 May; 39(7):1122-1126. PubMed ID: 38308154
[TBL] [Abstract][Full Text] [Related]
16. Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.
Sciria CT; Maddox TM; Marzec L; Rodwin B; Virani SS; Annapureddy A; Freeman JV; O'Hare A; Liu Y; Song Y; Doros G; Zheng Y; Lee JJ; Daggubati R; Vadlamani L; Cannon C; Desai NR
Clin Cardiol; 2020 Jul; 43(7):743-751. PubMed ID: 32378265
[TBL] [Abstract][Full Text] [Related]
17. Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020.
Navar AM; Kolkailah AA; Overton R; Shah NP; Rousseau JF; Flaker GC; Pignone MP; Peterson ED
J Am Heart Assoc; 2022 Nov; 11(22):e026723. PubMed ID: 36346063
[TBL] [Abstract][Full Text] [Related]
18. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
20. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB;
Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
